Skip to main content
Clinical Trials/CTRI/2024/06/069359
CTRI/2024/06/069359
Not yet recruiting
Phase 3

Evaluation of pulse dose corticosteroids in patients with severe alcoholic hepatitis - NI

Dr Prachis Ashdhir0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K701- Alcoholic hepatitis
Sponsor
Dr Prachis Ashdhir
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Prachis Ashdhir

Eligibility Criteria

Inclusion Criteria

  • All the patients greater than 18years of age with diagnosed Severe Alcoholic hepatitis with mDF (Maddrey’s Discriminant function) greater than 32 with or without underlying cirrhosis are included.

Exclusion Criteria

  • Patients with evidence of active GI bleed,active Infections/ Sepsis,patients with mDF greater than 90,patients with encephalopathy,patients with AKI/ Renal failure,patients requiring inotropic support,not willing to give consent.presence of other liver diseases and pregnant women.

Outcomes

Primary Outcomes

Not specified

Similar Trials